| Company: | NuVasive Inc, |
| Ticker Symbol: | NUVA |
| Class Period: | Oct-22-08 to Jul-30-13 |
| Date Filed: | Sep-23-13 |
| Lead Plaintiff Deadline: | Nov-22-13 |
| Court: | Southern District of California |
| Allegations: | |
NuVasive is a medical device company engaged in the design, development and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The Complaint alleges that defendants issued false and/or misleading statements and failed to disclose material adverse facts about NuVasive's business, operations and prospects. Specifically: (1) the Company improperly submitted false claims to Medicare and Medicaid in violation of federal and state laws and regulations; and (2) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.
On July 30, 2013, the Company disclosed that it had received a federal administrative subpoena from the Office of the Inspector General of the U.S. Department of Health and Human Services in connection with an investigation into "possible false or otherwise improper claims submitted to Medicare and Medicaid." As a result of this news, NuVasive securities declined $3.28 per share, or over 12%, to close at $22.84 per share on July 31, 2013.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
